Targeting leukemia stem cells.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Mitochondrial dynamics as a pathobiological mediator of clonal myeloid disorders.Cancer science · 2023
   Review
2. TIFAB accelerates MLL-AF9-Induced acute myeloid leukemia through upregulation of HOXA9.iScience · 2021
   Article
3. Leukemia Stem Cells in the Pathogenesis, Progression, and Treatment of Acute Myeloid Leukemia.Advances in experimental medicine and biology · 2019
   Article
4. AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.Cell stem cell · 2018
   Article
5. Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities.World journal of stem cells · 2016
   Review
6. Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance.Blood · 2014
   Article
7. Implantable microenvironments to attract hematopoietic stem/cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2012
   Article
8. Stemness of B-cell progenitors in multiple myeloma bone marrow.Clinical cancer research : an official journal of the American Association for Cancer Research · 2012
   Article
9. Targeting myelogenous leukemia stem cells: role of the circulation.Frontiers in oncology · 2012
   Article
10. Phenotypic heterogeneity of breast cancer stem cells.Journal of oncology · 2011
    Article
11. Are cancer stem cells radioresistant?Future oncology (London, England) · 2010
    Review

Corrections and comments

• Comment on
  Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML.2010

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as